Excited to launch?Intelligent Health Risk Assessment (IHRA)?as part of a?large-scale public health initiative in Chikkaballapur district. In collaboration with?Sri Madhusudan Sai Institute of Medical Sciences and Research, we are bringing?non-invasive metabolic screenings?to the grassroots level—empowering?2 lakh individuals?with?early detection of type 2 diabetes, hypertension, and cardiovascular risks. Prevention is Power in Practice—measurable, actionable, and transformative. And we are excited to be part of this?impact-driven initiative, ensuring that healthcare moves?from reactive treatment to proactive prevention. With timely insights and real-world interventions, we are making?public health more accessible, data-driven, and effective. Aarca Research remains committed to?scaling preventive healthcare, proving that early action saves lives. Grateful for the opportunity to contribute to a?healthier tomorrow. #PreventiveHealth #PublicHealth #MetabolicHealth #AarcaResearch #IHRA
Aarca Research
医疗设备制造业
A new method to deliver metabolic co-morbidities screening, painlessly and effectively!
关于我们
At Aarca Research, we're dedicated to transforming metabolic health with innovative, non-invasive technologies designed to detect, monitor, and manage health conditions before they escalate.
- 网站
-
https://www.aarcaresearch.com
Aarca Research的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Orange
- 类型
- 私人持股
- 创立
- 2019
- 领域
- machine learning、computer vision、healthtech、diagnostics和digitalhealth
地点
Aarca Research员工
动态
-
Aarca Research has been granted its?4th USPTO patent US 12,186,110 – Non-invasive, non-contact system and method for evaluating primary and secondary hypertension conditions using thermal imaging. Hypertension is often misdiagnosed due to limitations in conventional diagnostic methods, particularly in distinguishing between?primary (essential) hypertension, which develops gradually with no identifiable cause, and?secondary hypertension, which results from underlying conditions like kidney disease or hormonal disorders. This patented technique leverages thermal imaging to analyze vascular and metabolic patterns, enabling a more precise assessment of both forms of hypertension. By providing a non-invasive, contact-free, and scalable screening solution, this innovation enhances early detection, reduces misdiagnoses, and supports more targeted intervention strategies. This patent is a significant milestone in our mission to advance healthcare technology and plays a crucial role in non-invasive metabolic health management. #HealthcareInnovation #Hypertension #Metabolichealth #HealthcareTech
-
-
Thank you Social Alpha, Pfizer, NIPER Ahmedabad for this recognition of our product #NerveVue.
We are thrilled to announce the winners of the Pfizer INDovation NIPER-A Edition! Launched in partnership with the Department Of Pharmaceuticals, NITI Aayog, Atal Innovation Mission Official , NIPER Ahmedabad, Pfizer and Social Alpha, this initiative supports start-ups committed to solving critical healthcare challenges through affordable, easy-to-use diagnostic devices, making healthcare more accessible for all. Meet the six groundbreaking start-ups that are pushing the boundaries of healthcare innovation in India: ? Aarca Research ? bioLOCKEY Healthworks ? Utopic Tech Private Limited ? Babycue Pvt Ltd ? Brela Innovations Private Limited ? RNT Health Insights Stay tuned as we continue this journey through INDovation, driving forward healthcare solutions for all. Manoj Kumar | Meenakshi Nevatia | Dr. Kshama Kothari | Krishna Sree | Sharad Goswami | Sneha Senapati | Roma Nair | Vincent Lamoureux #DiagnosticsDecentralised #InvestedInImpact #Healthtech #HealthcareInnovation #PatientExperience #MedicalDiagnosis #Screening #EarlyDetection #Affordable #Accessible
-
Another patent for Aarca Research, granted by USPTO:?"US20220304578 - Non-invasive, non-contact system and method for measuring Diabetes Mellitus condition using thermal imaging" This is an important patent for the work we do in advancing healthcare technology and is instrumental in non-invasive metabolic health management. #HealthcareInnovation #Type2Diabetes #Metabolichealth #HealthcareTech
-
-
Technology is revolutionizing diabetes care, making it easier, more precise, and empowering people to monitor detection and diagnosis.?Aarca Research, founded by Gayathri Choda, is a story of innovation with a mission: to empower individuals with the tools they need for a healthier future. Through the power of computer vision, signal processing, and machine learning, their technology goes beyond traditional methods of diabetes detection and monitoring,?detecting not just diabetes, but also hypertension, in their very early stages – even before they become clinically diagnosable. Discover how women-led innovation is changing the direction for healthcare, visit our website to learn more: https://lnkd.in/g9nKz2pU #healthcare #healthtech #diabetes #nasscom #Tech.WE #nasscomdeeptech #nasscomstartups #deeptechfromIndia #WomeninTech #TechInnovation Kritika M | Shalini Dewan | Kalyan M. | Shreya Sharma | Nehal Pandya | Shivam Sareen | Mayank Kumar | Ashish Gupta | Ankita Puranik | Chowdry Vinay Kumar | Khushbu Gupta | Prashant verma | Arihant Kothari | RUTH MARY | Dr.Apoorva Joshi
-
-
Aarca Research has been granted the US patent for "Non-invasive, non-contact system and method for measuring Dyslipidemia condition using Thermal Imaging" Link: https://lnkd.in/gbYBx6zp
-
-
This #WorldHealthDay, we acknowledge the pivotal role of technology in revolutionizing healthcare, particularly in diabetes management. From continuous glucose monitors to smart insulin pens and diabetes management apps, technology is enhancing efficiency and accessibility in diabetes care, empowering individuals to lead fuller lives. Our startup, Aarca Research Pvt Ltd, is pioneering non-invasive diagnosis and maintenance procedures for diabetes and hypertension through innovative technology. Using computer vision, signal processing, and machine learning, their groundbreaking approach enables early detection of chronic conditions, facilitating preemptive treatment long before clinical diagnosis. As we reflect on the impact of technology in healthcare, let's embrace its transformative potential in shaping a healthier tomorrow. #HealthTech #DiabetesManagement #Innovation #nasscomstartups #nasscomdeeptech Kritika M | Shalini Dewan | Kalyan M. | Shreya Sharma | Nehal Pandya | Shivam Sareen | Mayank Kumar | Ashish Gupta | Ankita Puranik | Chowdry Vinay Kumar | Khushbu Gupta | Prashant verma | Arihant Kothari | Praghajieeth Shiyamraj | RUTH MARY | Dr.Apoorva Joshi
-